FDAnews
www.fdanews.com/articles/119879-results-from-phase-iia-retigabine-study-inconclusive

Results From Phase IIa Retigabine Study Inconclusive

August 24, 2009
Valeant Pharmaceuticals International announced Monday [that] preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia, a painful and common complication of shingles.
Yahoo! Finance